...Xiaohui Cai; Jinfei Wang; Jingtao Lu; Zhuxia Jia; Meiyu Chen; Jianfang Liu; Xuzhang Lu; Hongying Chao Mixed lineage leukemia ( MLL) T10 is a relatively rare partner for the KMT2A lysine (K)-specific methyltransferase 2A gene. The common features and coexisting mutations of acute myeloid leukemia...

...Nadav Mizrahi; Eitan Kugler; Lucille Hayman; Moshe Yeshurun; Alon Grossman; Pia Raanani; Ofir Wolach The co-occurrence of thymoma and T-lymphoblastic lymphoma/leukemia is an extremely rare but previously reported association that poses a diagnostic and therapeutic challenge. We describe a 67-year...

... to in the content or advertisements. 2019 Bibliometrics Citation classics Acute myelogenous leukemia Leukemia Neoplasms As medicine advances, there is also an ever increasing emergence of medical and scientific knowledge. This presents an urgent need to identify the most significant research...

... chemotherapy and their relationship with markers of immunoparalysis in leukemia patients. In 6 patients with acute myeloid leukemia or myelodysplastic syndrome and 12 healthy subjects, DAMPs, cytokines, and markers of immunoparalysis were determined before and during the first week after chemotherapy...

... polymorphism is associated with risk of leukemia and to determine its prognostic effect. Material and Methods: Studies published in PubMed, Embase and the Cochrane Controlled Trial Register were searched till June 2014 using the search terms ‘MDM2', ‘polymorphism' and ‘leukemia'. Results: Eleven studies were...

... genes in human cancers. The demethylating, dose-dependent effect of arsenic trioxide (As 2 O 3 ) on several tumor-related genes has already been postulated. However, whether such a demethylating effect also applies to the TMS1 gene in chronic myeloid leukemia cell line K562 cells has not been studied so...

..., instructions or products referred to in the content or advertisements. Leukemia Lymphoma In recent years there has been evidence of the increasing popularity of complementary medicine even in patients with hematological malignancies. One of the most frequently used complementary therapies...

...Yossi Cohen; Odit Gutwein; Osnat Garach-Jehoshua; Adina Bar-Haim; Abraham Kornberg Chemokines Gene expression Leukemia Multiple myeloma The chemokine CCL3/MIP-1α is expressed in multiple myeloma (MM) cells and directly stimulates osteoclast formation [ 1 ]. MIP-1α also enhances...

... the incidence of infection-related fever in 38 children, aged 2-16 years, with acute myeloid leukemia (AML) over 121 chemotherapy treatment cycles. A prophylactic group (n = 18) was given either vancomycin/cefepime (400 mg/m 2 , q12 h/50 mg/kg, q12 h) or piperacillin/tazobactam (110 mg/kg, q12 h). Control...

... with severe infections than without (8 vs. 39%; p ≤ 0.002). Patients who died by 12 weeks after GTX initiation were more likely to have leukemia (p = 0.03), not to have recovery of neutrophil counts (p < 0.0001), and to have started GTX during a critical care unit stay (p < 0.001). Uses of granulocyte...

... of leukemia. Methods: Ninety-three leukemia patients underwent allogeneic HSCT were divided into two groups: 51 cases of RD-HSCT and 42 cases of URD-HSCT. In the RD-HSCT group, a preconditioning regimen with fludarabine (Flu) + busulfan (Bu) + cytosine arabinoside (Ara-C) was used in 42 patients and total...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Invasive fungal disease Granulocyte macrophage colony-stimulating factor Stem cell transplant Leukemia Combination antifungal agents Immune suppression National Institutes...

... of evidence for the use of M-CSFs in hematological malignancies. The data were obtained from systematic reviews and meta-analyses of randomized controlled trials (RCTs) published in this field, particularly in: (a) acute leukemia (as primary prevention of infections and as priming); (b) malignant...

...Ron Ram; Anat Gafter-Gvili; Ofer Shpilberg; Pia Raanani In spite of decades of research in the field of allogeneic hematopoietic cell transplantation for the treatment of acute leukemia, controversies regarding the role of transplant still exist. These stem not only from contradictory results...

...Liyun Xiao; Yiqun Huang; Ruiji Zhen; J.W. Chiao; Delong Liu; Xudong Ma Objective: Since histone hypoacetylation due to excess histone deacetylases (HDACs) has been associated with transcriptional repression in leukemia, we aimed to determine deficient histone acetylation in patients with acute...

...H. Ohta; H. Nagase Serum muramidase values were greatly increased in all patients with monocytic leukemia, moderately elevated in chronic myelocytic leukemia, and only slightly increased in acute myelocytic leukemia. Serial estimations in patients with monocytic leukemia disclosed a sharp rise...

... leukemia. Acute myelocytic and lymphocytic leukemias show markedly enhanced values. Compared to thymidine kinase and DNA-polymerase, the very stable MS gives the same possibility to control the treatment of leukemic patients. 4 3 2009 © 1973 S. Karger AG, Basel 1973 Copyright / Drug Dosage...

...H. Ohta; Y. Matsuda Muramidase, acid phosphatase and nonspecific esterase were investigated in mononuclear cells of skin window exudate in normal persons and patients with various forms of leukemia. While acid phosphatase and nonspecific esterase gradually increased, muramidase activity was reduced...

...Alexander Dvilansky; Michael L. Alkan; Winston Ho; Helena Kaplan; Paskal Tiberin; Bracha Rachmilewitz Epidural myeloblastoma, which compressed the spinal cord, was the first evidence for chronic granulocytic leukemia, eosinophilic type, Ph chromosome negative. This manifestation was preceded by 3...

...M. Djaldetti; Iulia Rubinstein; U. Lewinski; M. Mandel A patient with acute lymphoblastic leukemia, whose red blood cells showed the abnormality ropalocytosis is described. This abnormality is characterized by bizzare pseudopodia like processes detectable in the mature red blood cells...